Royal Bank of Canada’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Royal Bank of Canada’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-25,636	Closed	-$384K	–	6793
2016 Q2	$384K	Sell	25,636 -84,655	-77%	-$1.09M	﹤0.01%	3918
2016 Q1	$1.34M	Buy	110,291 +83,905	+318%	+$1.18M	﹤0.01%	2799
2015 Q4	$420K	Buy	26,386 +23,371	+775%	+$368K	﹤0.01%	3939
2015 Q3	$46K	Buy	3,015 +1,749	+138%	+$37.8K	﹤0.01%	5181
2015 Q2	$30K	Buy	1,266 +215	+20%	+$5.15K	﹤0.01%	5490
2015 Q1	$24K	Sell	1,051 -2	-0.2%	-$53	﹤0.01%	5292
2014 Q4	$26K	Buy	+1,053	New	+$30.9K	﹤0.01%	5322
2014 Q2	–	Sell	-18,872	Closed	-$441K	–	6311
2014 Q1	$441K	Sell	18,872 -105	-0.6%	-$2.3K	﹤0.01%	3443
2013 Q4	$482K	Sell	18,977 -16,136	-46%	-$364K	﹤0.01%	3448
2013 Q3	$716K	Buy	35,113 +9,001	+34%	+$200K	﹤0.01%	3080
2013 Q2	$548K	Buy	+26,112	New	+$467K	﹤0.01%	3074

Royal Bank of Canada's SGNT Position: Q3 2016 in Review

Royal Bank of Canada sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 25,636 shares — an estimated $384K sold.

Royal Bank of Canada first reported a position in SGNT in Q2 2013 and held it in 11 quarters. The position peaked at $1.34M in Q1 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Royal Bank of Canada reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Royal Bank of Canada sold 25,636 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $384K.
Royal Bank of Canada first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 11 quarters.
Royal Bank of Canada's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.34M in Q1 2016.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Royal Bank of Canada's 13F filing for Q3 2016, filed 14 Nov 2016.